News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Molecular Hyperselection for Optimal First-Line Targeted Therapy in RAS Wild-Type Metastatic Colorectal Cancer
Photo: depositphotos.com
Apr 6, 2025, 14:06

Molecular Hyperselection for Optimal First-Line Targeted Therapy in RAS Wild-Type Metastatic Colorectal Cancer

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared an article by Lena Weiss, et al. on X:

“Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild metastatic colorectal cancer European Journal of cancer.”

Authors: Lena Weiss, Sebastian Stintzing, et al.

Molecular Hyperselection

More posts featuring Akhil Santhosh.

Akhil Santhosh cancer colorectal cancer European Journal of Cancer OncoDaily Oncology targeted therapy
Special Coverage
Blog
Apr 6, 2025, 14:06
Molecular Hyperselection for Optimal First-Line Targeted Therapy in RAS Wild-Type Metastatic Colorectal Cancer
Blog
Apr 6, 2025, 13:57
David Planchard: First patient included in the INDIGO study
Blog
Apr 6, 2025, 13:46
Terri Hansel: Proud of the incredible work at St. Elizabeth Breast Center and the Yung Family Center
Celebrities
Apr 6, 2025, 13:44
Cynthia Nixon's Breast Cancer Journey: How She Went Against, Survived, and More
Blog
Apr 6, 2025, 13:40
Oscar Tahuahua: Neoadjuvant Aumolertinib in stage III EGFR+ NSCLC
Insight
Apr 6, 2025, 13:37
Erick Saldanha: The role of ctDNA clearance as a biomarker of neoadjuvant immune checkpoint blockade in solid tumours
Opinion
Apr 6, 2025, 13:15
Sumanta Pal honors Evita Sadimin’s impact on oncology teams at the City of Hope Doctors Day Ceremony
Opinion
Apr 6, 2025, 12:55
Fumiko Ladd Chino: Toxicity in phase III oncology clinical trials is often incompletely reported
Insight
Apr 6, 2025, 12:51
Carolina Reduzzi and Lorenzo Gerratana on integrating CTCs and ctDNA in metastatic breast cancer management
Blog
Apr 6, 2025, 12:48
Join the AUA-IBCG Bladder Cancer Forum on April 28, 2–5 PM
Blog
Apr 6, 2025, 12:45
Supporting the development of NCCPs leads to better outcomes for everyone - UICC
Blog
Apr 6, 2025, 12:43
Yüksel Ürün: Dr. Kumar Prabhash Presents ALPHA-LUNG Study at POLES25